Lazăr Alexandra, Georgescu Anca Meda, Vitin Alexander, Azamfirei Leonard
Department of Anesthesiology and Intensive Care, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania.
Department of Infectious Diseases, University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania.
J Crit Care Med (Targu Mures). 2019 Aug 9;5(3):90-96. doi: 10.2478/jccm-2019-0017. eCollection 2019 Jul.
In recent years, a new form of medicine has become increasingly significant, namely, personalised medicine (PM). PM is a form of care in which treatment is tailored for an individual patient. PM is about using multiple data sets to create a digital human mapping. A person's biological traits are determined by the interactions of hundreds of genes and gene networks, as well as external factors such as diet and exercise. Combining and then investigating these multiple databases with powerful statistical tools, allows a new understanding of how genetic intricacy drives health and disease and so leads to a closer personalised medical approach that targets each individual's unique genetic make-up. Sepsis is a systemic inflammatory response to infection, ranging from systemic inflammatory response syndrome (SIRS) to septic shock and multiple organ dysfunction syndromes (MODS). Sepsis is the most common cause of death in intensive care patients. Treatments in an ICU may need to be adapted to the continuous and rapid changes of the disease, making it challenging to identify a single target. PM is thus seen as the future of sepsis treatment in the ICU. The fact that individual patients respond differently to treatment should be regarded as a starting point in the approach to providing treatment. The disease itself comes secondary to this concept.
近年来,一种新的医学形式变得越来越重要,即个性化医疗(PM)。个性化医疗是一种针对个体患者量身定制治疗方案的医疗形式。个性化医疗旨在利用多个数据集创建数字人体图谱。一个人的生物学特征由数百个基因和基因网络的相互作用以及饮食和运动等外部因素决定。通过强大的统计工具对这些多个数据库进行整合和研究,能够对基因复杂性如何驱动健康和疾病有新的认识,从而带来更贴近个性化的医疗方法,该方法针对每个人独特的基因构成。脓毒症是对感染的全身性炎症反应,范围从全身炎症反应综合征(SIRS)到感染性休克和多器官功能障碍综合征(MODS)。脓毒症是重症监护患者最常见的死亡原因。重症监护病房(ICU)的治疗可能需要适应疾病的持续快速变化,这使得确定单一靶点具有挑战性。因此,个性化医疗被视为重症监护病房脓毒症治疗的未来方向。个体患者对治疗反应不同这一事实应被视为提供治疗方法的出发点。相对于这个概念,疾病本身则是次要的。